Posterior-chamber phakic implantable collamer lenses with a central port: a review

Acta Ophthalmol. 2021 May;99(3):e288-e301. doi: 10.1111/aos.14599. Epub 2020 Aug 25.


We aimed to summarize the outcomes reported following the implantation of the V4c implantable collamer lens with a central port (ICL, STAAR Surgical Inc) for myopia correction. A literature search in PubMed, Web of Science and Scopus was carried out to identify publications reporting clinical outcomes of patients who were implanted with the V4c ICL model and had a follow-up period of at least 6 months. A total of 35 clinical studies published between 2012 and 2020 were included in the present review. A comprehensive analysis of the available data was performed, focusing on visual and refractive outcomes at different time-points post-surgery. In addition, adverse events and other parameters such as endothelial cell density, intraocular pressure and vault measurements-which were evaluated in some of the studies-were also compared. This review encompassed a total of 2904 eyes. The outcomes reported in this review lead us to conclude that ICL V4c implantation for myopia correction is a safe and efficient procedure, with stable visual and refractive outcomes and low adverse event rates. The patient's anterior segment should be thoroughly characterized, and the ICL parameters should be carefully selected so as to achieve good outcomes and avoid complications.

Keywords: adverse events; implantable collamer lens; intraocular pressure; myopia; phakic; refraction; vault; visual acuity.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Intraocular Pressure
  • Lens Implantation, Intraocular / methods*
  • Male
  • Myopia / surgery*
  • Phakic Intraocular Lenses / adverse effects
  • Phakic Intraocular Lenses / standards*
  • Refraction, Ocular
  • Visual Acuity